Waystar Holding Corp. WAY 深 滬
已收盤 02-06 16:00:00 美东时间
24.30
+0.170
+0.70%
華盛通- 最 高24.48
- 今 開24.145
- 成交量 261.59万股
- 最 低 23.66
- 昨 收 24.13
- 總市值 46.49亿
- 52周最高 48.11
- 市盈率 靜 --
- 換手率 1.37%
- 52周最低 23.23
- 委 比 59.21%
- 總股本 1.91亿
- 歷史最高 48.11
- 量 比 1.25
- 振 幅 3.40%
- 歷史最低 20.26
- 每 手 1
- 風險率 3.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Waystar Earns Continued Best in KLAS Honors
Recognition for Patient Access reflects strong client satisfaction with Waystar's industry-leading AI-powered platform LEHI, Utah and LOUISVILLE, Ky., Feb. 4, 2026 /PRNewswire/ -- Waystar (N...
02-04 22:26
Waystar Holding Corp. to Announce Fourth Quarter and Fiscal Year 2025 Financial Results
Waystar Holding Corp. to Announce Fourth Quarter and Fiscal Year 2025 Financial Results Waystar Holding Corp. will announce its fourth quarter and fiscal year 2025 financial results on February 17, 2026, before the market opens. The company will hold a conference call to discuss the results at 8:30
02-03 21:31
Waystar Introduces Agentic Intelligence To Its Cloud-Native Platform
Extends the impact of Waystar AltitudeAI, which has prevented $15.5 billion in denials in under one yearLeverages a unique combination of proprietary data from more than 7.5 billion annual transactions and one in
01-12 20:27
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Citigroup Maintains Buy on Waystar Holding, Lowers Price Target to $46
Citigroup analyst Daniel Grosslight maintains Waystar Holding (NASDAQ:WAY) with a Buy and lowers the price target from $49 to $46.
01-10 00:05
Wells Fargo Initiates Coverage On Waystar Holding with Overweight Rating, Announces Price Target of $41
Wells Fargo analyst Stan Berenshteyn initiates coverage on Waystar Holding (NASDAQ:WAY) with a Overweight rating and announces Price Target of $41.
01-09 21:43
Waystar to Present at J.P. Morgan Healthcare Conference
LEHI, Utah and LOUISVILLE, Ky., Dec. 29, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Off...
2025-12-29 22:00
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Barclays Maintains Overweight on Waystar Holding, Lowers Price Target to $42
Barclays analyst Saket Kalia maintains Waystar Holding (NASDAQ:WAY) with a Overweight and lowers the price target from $50 to $42.
2025-12-10 00:48
